近岸蛋白
(688137)
| 流通市值：10.80亿 | | | 总市值：23.19亿 |
| 流通股本：3267.54万 | | | 总股本：7017.54万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 687,774,177.07 | 647,351,227 | 668,950,856.76 | 1,131,075,224.33 |
| 应收票据及应收账款 | 62,916,585.14 | 59,959,090.49 | 62,733,487.23 | 58,400,195.18 |
| 应收账款 | 62,916,585.14 | 59,959,090.49 | 62,733,487.23 | 58,400,195.18 |
| 应收款项融资 | 5,988,871 | 2,061,250 | - | 325,250 |
| 预付款项 | 2,817,536.1 | 2,062,508.74 | 5,286,674.7 | 5,585,352.47 |
| 其他应收款合计 | 4,378,215.5 | 4,306,715.4 | 4,909,306.69 | 5,146,274.54 |
| 存货 | 70,609,687.64 | 76,083,001.99 | 80,153,890.81 | 78,702,688.7 |
| 其他流动资产 | 1,100,178,321.79 | 1,164,452,063.61 | 1,147,893,565.16 | 767,571,417.23 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,934,663,394.24 | 1,956,275,857.23 | 1,969,927,781.35 | 2,046,806,402.45 |
| 非流动资产: | | | | |
| 其他权益工具投资 | - | - | 10,000,000 | - |
| 其他非流动金融资产 | 10,000,000 | 10,000,000 | - | - |
| 固定资产 | 38,200,277.34 | 40,942,332.29 | 41,865,582.31 | 44,444,386.97 |
| 在建工程 | 91,336,880.79 | 74,949,007.6 | 53,812,936.04 | 36,473,932.84 |
| 使用权资产 | 50,571,453.09 | 54,248,303.65 | 65,896,219 | 70,735,248.62 |
| 无形资产 | 18,158,598.45 | 18,209,757.32 | 18,336,719.87 | 18,463,682.42 |
| 长期待摊费用 | 10,147,718.56 | 10,777,514.74 | 14,250,448.95 | 15,059,940.71 |
| 递延所得税资产 | 35,236,833.64 | 31,223,344.22 | 41,575,695.29 | 37,009,901.43 |
| 其他非流动资产 | 25,893,303.97 | 21,484,382.77 | 27,924,987.55 | 27,255,889.54 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 279,545,065.84 | 261,834,642.59 | 273,662,589.01 | 249,442,982.53 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,214,208,460.08 | 2,218,110,499.82 | 2,243,590,370.36 | 2,296,249,384.98 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 36,881,849.08 | 28,263,635.8 | 19,268,329.1 | 16,756,077 |
| 应付账款 | 36,881,849.08 | 28,263,635.8 | 19,268,329.1 | 16,756,077 |
| 合同负债 | 4,615,985.26 | 5,021,690.71 | 5,140,370 | 4,645,694.38 |
| 应付职工薪酬 | 10,481,383.6 | 9,757,838.8 | 7,485,431.72 | 7,390,039.41 |
| 应交税费 | 3,442,595.92 | 4,444,495.96 | 1,386,492.39 | 1,227,979.82 |
| 其他应付款合计 | 1,132,007.34 | 1,754,273.08 | 552,425.2 | 35,503,218.58 |
| 应付股利 | - | - | - | 35,087,719.5 |
| 一年内到期的非流动负债 | 15,111,833.93 | 17,407,184.6 | 18,114,873.02 | 17,687,365.85 |
| 其他流动负债 | 2,800,526.26 | 518,847.76 | 2,669,195.83 | 2,978,276.86 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 74,466,181.39 | 67,167,966.71 | 54,617,117.26 | 86,188,651.9 |
| 非流动负债: | | | | |
| 租赁负债 | 46,947,174.51 | 48,754,320.73 | 53,227,314.61 | 57,945,468.2 |
| 递延收益 | 239,393.03 | 520,492.51 | 938,283.17 | 960,457.94 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 47,186,567.54 | 49,274,813.24 | 54,165,597.78 | 58,905,926.14 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 121,652,748.93 | 116,442,779.95 | 108,782,715.04 | 145,094,578.04 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 70,175,439 | 70,175,439 | 70,175,439 | 70,175,439 |
| 资本公积 | 1,966,324,908.18 | 1,963,328,803.23 | 1,960,281,639.86 | 1,956,937,664.89 |
| 减:库存股 | 10,668,379.08 | 10,346,681.91 | 10,346,681.91 | - |
| 其他综合收益 | 175,398.1 | 153,411.19 | 182,763 | 174,466.36 |
| 盈余公积 | 18,341,366.76 | 18,341,366.76 | 18,341,366.76 | 18,341,366.76 |
| 未分配利润 | 48,206,978.19 | 60,015,381.6 | 96,173,128.61 | 105,525,869.93 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,092,555,711.15 | 2,101,667,719.87 | 2,134,807,655.32 | 2,151,154,806.94 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,092,555,711.15 | 2,101,667,719.87 | 2,134,807,655.32 | 2,151,154,806.94 |
| 负债和股东权益合计 | 2,214,208,460.08 | 2,218,110,499.82 | 2,243,590,370.36 | 2,296,249,384.98 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-30 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |